DEF 14A: Kemper Corporation Files Definitive Proxy Statement for 2024 Annual Meeting

Kemper Corporation has released its definitive proxy statement, outlining key proposals for the upcoming 2024 Annual Meeting of Shareholders, including director elections, executive compensation, and an amendment to the 2023 Omnibus Plan.

Summary

• Kemper Corporation has filed a definitive proxy statement for its 2024 Annual Meeting of Shareholders, scheduled for May 1, 2024.
• The proxy statement details proposals to be voted on, including the election of ten directors, an advisory vote on executive compensation, approval of an amended and restated 2023 Omnibus Plan, and ratification of Deloitte & Touche LLP as the company's independent registered public accounting firm for 2024.
• The Board of Directors recommends voting FOR all director nominees, the advisory vote on executive compensation, the amended and restated 2023 Omnibus Plan, and the ratification of Deloitte & Touche LLP.
• The Kemper Foundation will donate $1 to the American Cancer Society for every shareholder account that votes in connection with the Annual Meeting.
• The company engaged directly with approximately 30 shareholders and approximately 10 conferences and group meetings in 2023.
• Kemper's conversations with shareholders in 2023 covered a variety of topics including strategic initiatives, the company's operating environment and financial performance, and the path to return to profitability.
• The Board has decided to separate the roles of Chairman and CEO effective at the 2024 Annual Meeting.
• The Board approved the Amended and Restated Kemper Corporation 2023 Omnibus Plan to increase the maximum number of shares available under the 2023 Omnibus Plan by 800,000 shares, subject to approval of the shareholders at the Annual Meeting.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral and factual manner. The sentiment is slightly positive due to the company's commitment to shareholder engagement and good corporate governance.

Positives

• The Kemper Foundation's donation to the American Cancer Society for each shareholder account that votes incentivizes participation.
• The company actively engages with shareholders to gather feedback and address concerns.
• The Board is committed to good corporate governance and has decided to separate the roles of Chairman and CEO.
• The company has a strong focus on ESG (Environmental, Social, and Governance) practices.
• The company has a charitable matching gift program for non-employee directors, up to $10,000 per year.
• The company prohibits hedging, pledging or otherwise encumbering shares of the Company's Common Stock.

Risks

• Forward-looking statements are subject to risks and uncertainties, and actual results could differ materially.
• Operational challenges, including macro-economic trends, impacted Kempers annual performance results and the insurance industry more generally.

Future Outlook

The company plans to continue its practice of shareholder outreach, including discussions regarding executive compensation practices, by again soliciting the views of investors.

Management Comments

• Feedback from shareholders is shared with the Board and directly informed the Boards consideration of strategy, compensation and ESG matters in 2023.
• We are committed to maintaining an active dialogue to understand the priorities and concerns of our shareholders, and believe ongoing engagement builds mutual trust and understanding.

Industry Context

The proxy statement provides insights into Kemper's corporate governance practices, executive compensation strategies, and shareholder engagement efforts, which are relevant to understanding the company's position within the insurance industry.

Comparison to Industry Standards

• The document mentions a peer group of 19 publicly-traded companies in the insurance industry used for executive compensation benchmarking, including American Equity, Hartford Financial, and Cincinnati Financial.
• The document references leading global standards, including the Sustainability Accounting Standards Board and Global Reporting Initiative.

Corporate Governance

Related Party Transactions

• The Governance Committee reviewed transactions with affiliates of United Airlines Holdings Inc. and Teladoc Health, Inc. and determined that they do not create a material relationship with the Company and are consistent with the best interests of the Company and its shareholders.

Stakeholder Impact

• Shareholders have the opportunity to vote on key proposals that will shape the company's future.
• Employees are impacted by the executive compensation program and the Amended and Restated 2023 Omnibus Plan.
• The company's ESG initiatives impact the broader community and environment.

Next Steps

• Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
• The Board will consider the recommendation of the Governance Committee and elect one of the independent directors to serve as Chairman at its May 2024 meeting.

Key Dates

Keywords

proxy statement, annual meeting, shareholders, directors, executive compensation, omnibus plan, Deloitte & Touche, corporate governance, ESG, Kemper